Inflammatory Bowel Disease (IBD) Disclosures

Total Page:16

File Type:pdf, Size:1020Kb

Inflammatory Bowel Disease (IBD) Disclosures Game of Crohn’s: The good, the bad and the ugly sides of Inflammatory Bowel Disease (IBD) Disclosures None to report Introduction Learning Objective(s) • Describe and differentiate the epidemiology, pathophysiology, intestinal and extra-intestinal clinical presentation, laboratory, endoscopic, and radiological diagnostic assessment and findings, pharmaceutical and surgical treatment options, and potential complications of Crohn’s Disease vs. Ulcerative Colitis Inflammatory Bowel Disease (IBD) By Definition Inflammatory Bowel Disease n. Abbr. IBD A chronic disorder of the gastrointestinal tract, especially Crohn's disease or an ulcerative form of colitis (inflammation of the inner lining of the colon) Two Main Types Setting the Scene… IBD Overview There is NO cure IBD is a result of an immune response against the bodies own intestinal system Most commonly begins in early 20’s to 30’s, but also seen in 50- 80 year old’s (but this peak is mainly for CD) Not contagious Cause UNKNOWN Both are characterized by diarrhea and abdominal pain Risk Factors Age and gender: 15-40 years of age 2nd peak 50-80 years of age (CD) Slight female predominance in CD Slight male predominance in UC Race and ethnicity: Jews Lower in black and Hispanic populations Genetic susceptibility Etiology Unknown but several contributing factors include: Infectious Environmental Diet Obesity NSAID or aspirin use (Cyclooxygenase-mediated disruption of the intestinal epithelial barrier) Psychosocial factors – NO consistent psychopathology Smoking – negative correlation between smoking and UC (smoking may even decrease the risk of flares) but a positive correlation between smoking and CD recurrence Genetics Activation of the immune system is the cause of the inflammation in IBD It is believed that genetics plays a major role but no specific trigger has been identified. First degree relatives 3-20 times more likely to develop IBD Genetic factors more important in CD than in UC First confirmed IBD gene (IBD1) confers increased risk of CD Clinical features of CD demonstrate a heritable pattern with concordance in disease location Over 100 distinct susceptibility loci for IBD Several genetic syndromes have been associated with IBD including Turners syndrome, Hermansky-Pudlak syndrome, and glycogen storage disease type 1b Symptoms Abdominal cramps and pain - common Diarrhea (can be bloody) - common Urgency Fever Loss of appetite Weight loss Fatigue Vomiting Anemia Ulcerative Colitis Ulcerative Colitis Limited to mucosal layer of the colon Toxic megacolon (clinical term, aka toxic colitis) Bleeding from ulcers The appearance of the mucosa in UC varies depending on the extent of the disease. The inflammation always begins in the distal rectum and spreads proximally in continuous fashion. The characteristic histologic lesion - is the crypt abscess (typical but not diagnostic) Extent of Involvement of Colon in UC Ulcerative proctitis - limited to the rectum Ulcerative proctosigmoiditis - limited to the rectum and sigmoid colon and not involving the descending colon Left-sided or distal ulcerative colitis - is disease that extends beyond the rectum and as far proximally as the splenic flexure Extensive colitis - disease extending proximal to the splenic flexure but sparing the cecum Pancolitis is used when the inflammatory process extends beyond the splenic flexure to the cecum Toxic Megacolon Rare, life-threatening form of ulcerative colitis Signs include Fever >101oF/38.6oC Tachycardia Abdominal distention Signs of localized or generalized peritonitis Leukocytosis A dilated colon It may occur anytime during the course of UC but usually occurs early on Toxic Megacolon: Presentation Jalan et al described the diagnostic criteria, which are as follows: Radiographic evidence of colonic dilatation - The classic finding is more than 6 cm in the transverse colon Any 3 of the following - Fever (>101.5°F; 38.6°C), tachycardia (>120 beats/min), leukocytosis (>10.5 x 10 3/µL), or anemia Any 1 of the following - Dehydration, altered mental status, electrolyte abnormality, or hypotension Toxic Megacolon: Pathophysiology & Epidemiology Although the precise pathophysiology is unproven, several factors may contribute to its development and precipitation The microscopic hallmark of TM is inflammation extending beyond the mucosa into the smooth-muscle layers and serosa The lifetime risk of TM in ulcerative colitis has been estimated to be 1-2.5% No data exist regarding race or gender and the incidence of TM Toxic Megacolon: Treatment • Treatment of TM includes 3 main goals: 1. Reduce colonic distention to prevent perforation, 2. Aggresive correction of fluid and electrolyte disturbances, and 3. Treatment of toxemia and precipitating factors with broad-spectrum antibiotics • Careful and frequent monitoring of the patient is required, especially in the first 12 hours • Patients should be put on bowel rest, and a nasogastric tube (NGT) or long intestinal tube should be placed to assist with gastrointestinal decompression Toxic Megacolon: Prognosis The survival prognosis of TM should be excellent in the absence of perforation In the case of ulcerative colitis, a proctocolectomy cures patients of the disease With the use of tumor necrosis factor (TNF)-alpha inhibitors, it is hoped that more cases can be managed medically in future Crypt Abscess “The tubular crypt of Leiberkuhn rounds the corner, in and out of the plane of section twice, giving it a double look. Contrast the healthy crypts at the left edge with the abscessed crypt, and the neutrophils in the crypt abscess with the lymphocytes and plasma cells between the crypts.” Crohn’s Disease Crohn’s Disease Transmural inflammation and skip lesions Mouth to anus Obstruction and strictures Perforation of bowel Abscesses (up to 20 percent; intra-abdominal or extra-abdominal) Fissures (40 percent; a small tear) and fistulas (an abnormal connection between organs) Clinical manifestations of CD more variable than UC Fatigue Prolonged diarrhea with abdominal pain with or without gross bleeding Weight loss Fever malabsorption Malignancy Risk and incidence increases 8-10 years after diagnosis The extent of colonic involvement and the duration of the disease are strongly correlated with cancer risk Extraintestinal Complications • Depression • Arthritis • Liver and kidney disorders including renal stones • Inflammation of the eye (Anterior Uveitis) • Skin conditions (Erythema Nodosum / Pyoderma Gangrenosum) • Bone loss and osteoporosis • Primary Sclerosing Cholangitis • Venous and arterial thromboembolism • Vitamin B12 deficiency • Spondyloarthropathy and ankylosing spondylitis Physical Examination For UC & CD physical examination is often normal at presentation Some of the findings that may be seen include: pallor evidence of weight loss abdominal tenderness red blood on rectal examination Crohn’s disease - More specific findings include perianal skin tags and sinus tracts Routine Laboratory Studies Tests that may be done but do not confirm IBD include: Fecal occult blood test Complete blood count (CBC) Blood chemistry including electrolytes, renal function tests, liver enzymes, and blood glucose Erythrocyte sedimentation rate (ESR) C-reactive protein (CRP) Serum iron and vitamin B12 level Stool Cultures – Ova and Parasites, C. Difficile, Giardia stool antigen test STI – for UC Antibody Tests – used to distinguish between CD and UC and to determine the probability of IBD vs. other types of colitis Antibody Tests Antineutrophil cytoplasmic antibodies (pANCA) and anti- Saccharomyces cerevisiae antibodies (ASCA) The sensitivity of the antibody tests alone or in combination was in the range of 40 to 60 percent, and the specificity was greater than 90 percent for distinguishing patients with IBD from controls. Anti-OmpC antibody – The anti-OmpC antibody has been identified as a potential serologic marker of IBD Diagnosis Characteristic history Typical endoscopic appearance of the mucosa Confirmatory histology seen on colonic biopsy Diagnostic Studies for IBD • Upper GI series with small bowel follow through (SBFT) – initial study • Barium enema • Contrasted CT scan – used more to determine complications of the disease such as abscesses or fistulas rather than for specific diagnosis • May show marked thickening of bowel wall in UC, but finding is nonspecific • Endoscopy – preferred study • Small bowel enteroscopy • Capsule endoscopy • EGD (ulcerations occur in the stomach and duodenum in 5-10% of patients with crohn’s disease) Endoscopy Findings in UC In mild disease: A fine granular appearing mucosa In more severe disease: Discrete ulcers are seen In long-standing disease: Loss of haustral markings Shortening of the colon Tubular appearance of the colon along with pseudopolyps Endoscopy Findings in CD Characteristic findings of small bowel disease include: Skip lesions Cobblestoning Luminal narrowing Characteristic findings on colonoscopy include: Aphthae ulcers (small shallow ulcers with a red halo) Skip lesions Rectal sparing Differential Diagnosis Broad - because of the segmental nature of CD, a variety of disorders can mimic its clinical presentation IBS Lactose intolerance Infectious colitis Appendicitis Diverticulitis Diverticular colitis Ischemic colitis Perforating or obstructing carcinoma Lymphoma Chronic ischemia Endometriosis and carcinoid - NB: Can both give a radiologic and clinical picture that is easily confused
Recommended publications
  • Adult Congenital Megacolon with Acute Fecal Obstruction and Diabetic Nephropathy: a Case Report
    2726 EXPERIMENTAL AND THERAPEUTIC MEDICINE 18: 2726-2730, 2019 Adult congenital megacolon with acute fecal obstruction and diabetic nephropathy: A case report MINGYUAN ZHANG1,2 and KEFENG DING1 1Colorectal Surgery Department, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310000; 2Department of Gastrointestinal Surgery, Yinzhou Peoples' Hospital, Ningbo, Zhejiang 315000, P.R. China Received November 27, 2018; Accepted June 20, 2019 DOI: 10.3892/etm.2019.7852 Abstract. Megacolon is a congenital disorder. Adult congen- sufficient amount of bowel should be removed, particularly the ital megacolon (ACM), also known as adult Hirschsprung's aganglionic segment (2). The present study reports on a case of disease, is rare and frequently manifests as constipation. ACM a 56-year-old patient with ACM, fecal impaction and diabetic is caused by the absence of ganglion cells in the submucosa nephropathy. or myenteric plexus of the bowel. Most patients undergo treat- ment of megacolon at a young age, but certain patients cannot Case report be treated until they develop bowel obstruction in adulthood. Bowel obstruction in adults always occurs in complex clinical A 56-year-old male patient with a history of chronic constipa- situations and it is frequently combined with comorbidities, tion presented to the emergency department of Yinzhou including bowel tumors, volvulus, hernias, hypertension or Peoples' Hospital (Ningbo, China) in February 2018. The diabetes mellitus. Surgical intervention is always required in patient had experienced vague abdominal distention for such cases. To avoid recurrence, a sufficient amount of bowel several days. Prior to admission, chronic bowel obstruction should be removed, particularly the aganglionic segment.
    [Show full text]
  • Toxic Colonoscopy—How Investigating Active Inflammatory Bowel Disease
    Images in… BMJ Case Reports: first published as 10.1136/bcr-2015-209769 on 22 July 2015. Downloaded from Toxic colonoscopy—how investigating active inflammatory bowel disease can lead to the serious complication of toxic megacolon Shohib Tariq,1 Assad Farooq,1 Ibrar Ali,2 Haren Wijesinghe3 1University Hospital of North DESCRIPTION absent. Abdominal radiograph (figure 2)showed Midlands NHS Trust, Stafford, A 15-year-old girl presented to accident and emer- dilated bowel and CT scanning confirmed toxic mega- West Midlands, UK fi 2Heart of England Foundation gency A&E unable to cope after a week-long colon ( gures 3 and 4), although no perforation. Trust, Birmingham, West history of abdominal pain with vomiting and The patient was made nil by mouth; hydrocorti- Midlands, UK blood-streaked diarrhoea. sone, intravenous cefotaxime and metronidazole 3 University Hospital The patient had been known to the gastroenter- were started as per guidelines.1 Birmingham, Queen Elizabeth, ologist for suspected inflammatory bowel disease With pain improving the following day and radi- Birmingham, West Midlands, UK and was due for an outpatient endoscopy. ology showing improvement in dilation, diet was On examination, the patient was febrile and reintroduced once bowel sounds returned. Correspondence to tachycardic. There were no mouth ulcers or skin There is evidence to suggest colonoscopy2 and Dr Shohib Tariq, changes, however, finger clubbing was present, bowel preparation3 may have caused the exacerba- [email protected] there was guarding and the patient was tender in tion of ulcerative colitis leading to toxic Accepted 9 July 2015 all quadrants. There were no palpable masses or megacolon.
    [Show full text]
  • The Onset of Clinical Manifestations in Inflammatory Bowel Disease Patients
    AG-2018-65 ORIGINAL ARTICLE dx.doi.org/10.1590/S0004-2803.201800000-73 The onset of clinical manifestations in inflammatory bowel disease patients Viviane Gomes NÓBREGA1, Isaac Neri de Novais SILVA1, Beatriz Silva BRITO1, Juliana SILVA1, Maria Carolina Martins da SILVA1 and Genoile Oliveira SANTANA2,3 Received 29/10/2017 Accepted 10/8/2018 ABSTRACT – Background – The diagnosis of inflammatory bowel disease is often delayed because of the lack of an ability to recognize its major clinical manifestations. Objective – Our study aimed to describe the onset of clinical manifestations in inflammatory bowel disease patients. Methods – A cross-sec- tional study. Investigators obtained data from interviews and the medical records of inflammatory bowel disease patients from a reference centre located in Brazil. Results – A total of 306 patients were included. The mean time between onset of symptoms and diagnosis was 28 months for Crohn’s disease and 19 months for ulcerative colitis. The main clinical manifestations in Crohn’s disease patients were weight loss, abdominal pain, diarrhoea and asthenia. The most relevant symptoms in ulcerative colitis patients were blood in the stool, faecal urgency, diarrhoea, mucus in the stool, weight loss, abdominal pain and asthenia. It was observed that weight loss, abdominal pain and distension, asthenia, appetite loss, anaemia, insomnia, fever, nausea, perianal disease, extraintestinal manifestation, oral thrush, vomiting and abdominal mass were more frequent in Crohn’s patients than in ulcerative colitis patients. The frequencies of urgency, faecal incontinence, faeces with mucus and blood, tenesmus and constipation were higher in ulcerative colitis patients than in Crohn’s disease patients.
    [Show full text]
  • Ulcerative Proctitis
    Patient & Family Guide 2016 Ulcerative Proctitis www.nshealth.ca Ulcerative Proctitis What is Inflammatory Bowel Disease? Inflammatory bowel disease (IBD) is the general name for diseases that cause inflammation (swelling and irritation) in the intestines (“gut”). It includes the following: • Ulcerative proctitis • Crohn’s disease • Ulcerative colitis What are your questions? Please ask. We are here to help you. 1 What is ulcerative proctitis and how is it different from ulcerative colitis? Ulcerative proctitis (UP) is a type of ulcerative colitis (UC). UC is an inflammatory disease of the colon (large intestine or large bowel). The inner lining of the colon becomes inflamed and has ulcerations (sores). The entire large bowel is involved in UC. When only the lowest part of the colon is involved (the rectum, 15 to 20 cm from the anus), it is called ulcerative proctitis. 15-20 cm Rectum Large intestine (large bowel) 2 How is ulcerative proctitis diagnosed? • A test called a sigmoidoscopy will tell us if you have this problem. The doctor uses a special tube which bends and has a small light and camera on the end to look at the inside of your lower bowel and rectum. The tube is passed through the anus to the rectum and into the last 25 cm of the large bowel. • A biopsy (small piece of bowel tissue is taken) during the test and sent to the lab for study. • Most people do not find the test and biopsy uncomfortable and medicine to relax or make you sleepy is not usually needed. What are the symptoms of ulcerative proctitis? • Rectal bleeding and itching, passing mucus through the rectum, and feeling like you always need to pass stool (poop) even though your bowel is empty.
    [Show full text]
  • Ulcerative Proctitis
    Ulcerative Proctitis Ulcerative proctitis is a mild form of ulcerative colitis, a ulcerative proctitis are not at any greater risk for developing chronic inflammatory bowel disease (IBD) consisting of fine colorectal cancer than those without the disease. ulcerations in the inner mucosal lining of the large intestine that do not penetrate the bowel muscle wall. In this form of colitis, Diagnosis the inflammation begins at the rectum, and spreads no more Typically, the physician makes a diagnosis of ulcerative than about 20cm (~8″) into the colon. About 25-30% of people proctitis after taking the patient’s history, doing a general diagnosed with ulcerative colitis actually have this form of the examination, and performing a standard sigmoidoscopy. A disease. sigmoidoscope is an instrument with a tiny light and camera, The cause of ulcerative proctitis is undetermined but there inserted via the anus, which allows the physician to view the is considerable research evidence to suggest that interactions bowel lining. Small biopsies taken during the sigmoidoscopy between environmental factors, intestinal flora, immune may help rule out other possible causes of rectal inflammation. dysregulation, and genetic predisposition are responsible. It is Stool cultures may also aid in the diagnosis. X-rays are not unclear why the inflammation is limited to the rectum. There is a generally required, although at times they may be necessary to slightly increased risk for those who have a family member with assess the small intestine or other parts of the colon. the condition. Although there is a range of treatments to help ease symptoms Management and induce remission, there is no cure.
    [Show full text]
  • Etiology and Management of Toxic Megacolon with Human
    GASTROENTEROLOGY 1994;107:898-883 Etiology and Management of Toxic Megacolon in Patients With Human lmmunodeficiency Virus Infection LAURENT BEAUGERIE,* YANN NG&* FRANCOIS GOUJARD,’ SHAHIN GHARAKHANIAN,§ FRANCK CARBONNEL,* JACQUELINE LUBOINSKI, ” MICHEL MALAFOSSE,’ WILLY ROZENBAUM,§ and YVES LE QUINTREC* Departments of *Gastroenterology, ‘Surgery, %fectious Diseases, and llPathology, Hdpital Rothschild, Paris, France We report six cases of toxic megacolon in patients with megacolon, we opted for nonsurgical treatment of colonic human immunodeficiency virus (HIV). One case, at an decompression and anti-CMV treatment with a favorable early stage of HIV infection, mimicked a severe attack short-term outcome. of Crohn’s disease, with a negative search for infec- tious agents. Subtotal colectomy was successfully per- Case Report formed with an uneventful postoperative course. The All of the cases of toxic megacolon in patients with five other cases concerned patients with acquired im- HIV seen at Rothschild Hospital between 1988 and 1992 were munodeficiency syndrome at a late stage of immunode- reviewed. During this period, 2430 patients were seen in the ficiency. They were related to Clostridium ditTcile or hospital for HIV infection. Diagnostic criteria for toxic mega- cytomegalovirus (CMV) intestinal infection in two and colon were defined as follows: (1) histologically proven colitis; three patients, respectively. One case of CMV colitis (2) radiological dilatation of the transverse colon on x-ray film presented macroscopically and histologically as pseu- of the abdomen with a colonic diameter above 6 cm at the domembranous colitis. Emergency subtotal colectomy, point of maximum dilatation’*; and (3) evidence of at least performed in the first four patients with acquired immu- two of these following signs’: tachycardia greater than 100 nodeficiency syndrome was followed by a fatal postop beats per minute, body temperature >38.6”C, leukocytosis erative outcome.
    [Show full text]
  • Toxic Megacolon with Colonic Ischemia Masquerading As Diabetic Ketoacidosis: a Case Report F
    Saudi Journal of Medical and Pharmaceutical Sciences Abbreviated Key Title: Saudi J Med Pharm Sci ISSN 2413-4929 (Print) |ISSN 2413-4910 (Online) Scholars Middle East Publishers, Dubai, United Arab Emirates Journal homepage: https://saudijournals.com/sjmps Case Report Toxic Megacolon with Colonic Ischemia Masquerading as Diabetic Ketoacidosis: A Case Report F. Mansouri* Department of Pediatrics, King Abdulaziz University, Jeddah, Saudi Arabia DOI: 10.36348/sjmps.2020.v06i01.010 | Received: 03.01.2020 | Accepted: 15.01.2020 | Published: 22.01.2020 *Corresponding author: Mansouri F Abstract A previously healthy 12-year-old boy presented with abdominal pain and clinical and laboratory features highly suggestive of diabetic ketoacidosis. When his blood glucose plummeted and his urinary ketones disappeared within the first hour of insulin therapy, while his abdominal pain, acidosis and hemodynamic status failed to improve despite vigorous fluid resuscitation, the diagnosis of diabetic ketoacidosis was questioned. At laparotomy, gangrenous, hugely dilated large bowel was found, requiring a subtotal colectomy from the cecum to the sigmoid colon; leaving the patient with an ileostomy. The child survived a complicated postoperative course and is currently doing well. Keywords: Ischemic bowel, toxic megacolon, diabetic ketoacidosis. Copyright @ 2020: This is an open-access article distributed under the terms of the Creative Commons Attribution license which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use (NonCommercial, or CC-BY-NC) provided the original author and source are credited. NTRODUCTION never been on any treatment and had been incompliant I with dietary modifications. 4 days prior to presentation, Twenty percent to 40% of children with newly he had progressively worsening episodes of abdominal diagnosed insulin-dependent (type-I) diabetes mellitus pain, mainly in his right lower quadrant (RLQ).
    [Show full text]
  • Megacolon Toxic of Idiophatic Origin: Case Report
    DOI: http://dx.doi.org/10.22516/25007440.256 Case report Megacolon toxic of idiophatic origin: case report Sergio Andrés Siado,1 Héctor Conrado Jiménez,2 Carlos Mauricio Martínez Montalvo.3 1 General Surgeon at Clinica Belo Horizonte and Abstract Clinica Medilaser in Neiva, Huila, Colombia 2 Epidemiologist and second year resident in general Toxic megacolon is a pathology whose mortality rate is over 80%. A progressive inflammatory process com- surgery at Universidad Surcolombiana and the promises the colon wall, and secondary dilation of the intestinal lumen occurs due to inflammatory or in- Hospital Universitario Hernando Moncaleano fectious processes. Its clinical presentation is bizarre. but the basic pillars for management are opportune Perdomo in Neiva, Huila, Colombia 3 General Practitioner at the Universidad diagnosis and adequate medical management with antibiotics, water resuscitation, and metabolic correction. Surcolombiana in Neiva, Huila, Colombia If necessary, effective surgical management can prevent the development of complications that worsen the disease and the prognosis of a patient. In this article we present the case of a patient who died after deve- Corresponding author: Carlos Mauricio Martinez Montalvo. [email protected] loping septic shock secondary to toxic megacolon. Cholangitis grade III was suspected, but discarded after ultrasonography, and this resulted in generated distortions in approach and initial management. Due to clinical ......................................... deterioration and abdominal distension, the patient underwent diagnostic laparoscopy which revealed severe Received: 08-08-17 Accepted: 13-04-18 ischemic compromise of the entire colon but without involvement of the small intestine. For this reason, a total colectomy was performed. The pathology report and clinical history ruled out ulcerative colitis or Crohn’s disease which confirmed the diagnosis of toxic megacolon.
    [Show full text]
  • Mimicry and Deception in Inflammatory Bowel Disease and Intestinal Behçet Disease
    Mimicry and Deception in Inflammatory Bowel Disease and Intestinal Behçet Disease Erika L. Grigg, MD, Sunanda Kane, MD, MSPH, and Seymour Katz, MD Dr. Grigg is a Gastroenterology Fellow Abstract: Behçet disease (BD) is a rare, chronic, multisystemic, inflam- at Georgia Health Sciences University in matory disease characterized by recurrent oral aphthous ulcers, genital Augusta, Georgia. Dr. Kane is a Professor ulcers, uveitis, and skin lesions. Intestinal BD occurs in 10–15% of BD of Medicine in the Division of Gastro- patients and shares many clinical characteristics with inflammatory enterology and Hepatology at the Mayo Clinic in Rochester, Minnesota. Dr. Katz bowel disease (IBD), making differentiation of the 2 diseases very diffi- is a Clinical Professor of Medicine at cult and occasionally impossible. The diagnosis of intestinal BD is based Albert Einstein College of Medicine in on clinical findings—as there is no pathognomonic laboratory test—and Great Neck, New York. should be considered in patients who present with abdominal pain, diarrhea, weight loss, and rectal bleeding and who are susceptible to Address correspondence to: intestinal BD. Treatment for intestinal BD is similar to that for IBD, but Dr. Seymour Katz overall prognosis is worse for intestinal BD. Although intestinal BD is Albert Einstein College of Medicine extremely rare in the United States, physicians will increasingly encoun- 1000 Northern Boulevard ter these challenging patients in the future due to increased immigration Great Neck, NY 11021; rates of Asian and Mediterranean populations. Tel: 516-466-2340; Fax: 516-829-6421; E-mail: [email protected] ehçet disease (BD) is a rare, chronic, recurrent, multisys- temic, inflammatory disease that was first described by the Turkish dermatologist Hulusi Behçet in 1937 as a syndrome Bwith oral and genital ulcerations and ocular inflammation.1,2 Prevalence BD is more common and severe in East Asian and Mediter- ranean populations.
    [Show full text]
  • Toxic Megacolon with Late Perforation in Campylobacter Colitis
    Postgrad Med J: first published as 10.1136/pgmj.69.810.322 on 1 April 1993. Downloaded from 322 CLINICAL REPORTS To our knowledge this is the first report of angiography and surgery makes it unlikely that the recurrent anaemia without frank gastrointestinal ischaemic changes observed were due to cholesterol haemorrhage as a presentation of cholesterol embolism at aortic instrumentation. It is possible embolism. This elderly male patient, athough not that the episode of small bowel obstruction was hypertensive, had many risk factors for this disease: also a sequel of cholesterol embolism, since the he was a diabetic, an ex-smoker and had evidence healing process following an episode of extensive of generalized atherosclerosis. We cannot be cer- mucosal ischaemia can result in concentric fibrosis tain in retrospect for how long cholesterol embo- and narrowing of the bowel lumen.3 lism in the superior mesenteric axis was the source This case illustrates that cholesterol embolism ofblood loss, but right hemicolectomy appeared to should be considered as a possible cause of unex- be curative in this case and no other cause for plained gastrointestinal blood loss in an elderly bleeding was found on close examination of the patient with atherosclerosis. specimen. The interval of one month between References 1. Fine, M.J., Kapoor, W. & Falanga, V. Cholesterol crystal 8. Queen, M., Biem, H.J., Moe, G.W. & Sugar, L. Development embolization: a review of 221 cases in the English literature. of cholesterol embolization after intravenous streptokinase Angiology 1987, 38: 769-784. for acute myocardial infarction. Am J Cardiol 1990, 65: 2.
    [Show full text]
  • Coping with the Problems of Diagnosis of Acute Colitis
    Diagnostic and Interventional Imaging (2013) 94, 793—804 . CONTINUING EDUCATION PROGRAM: FOCUS . Coping with the problems of diagnosis of acute colitis a,∗,c b a E. Delabrousse , F. Ferreira , N. Badet , a b M. Martin , M. Zins a Urinogenital and Digestive Imaging Department, hôpital Jean-Minjoz, CHRU de Besanc¸on, 3, boulevard Fleming, 25030 Besanc¸on, France b Radiology Department, hôpital Saint-Joseph, 184, rue Raymond-Losserand, 75014 Paris, France c EA 4662, Nanomedicine Laboratory, Imagery and Therapeutics, University of Franche-Comté, Besanc¸on, France KEYWORDS Abstract Acute colitis is an acute condition of the colon. For the radiologist, it is mainly Colitis; diagnosed during differential diagnosis of acute abdominal conditions. There are many causes Ischaemia; of colitis and the degree of its severity varies. A CT scan is the best imaging examination for IBD; diagnosing it and also for analysing and characterising colitis. The topography, type of lesion Pseudomembranous; and associated factors can often suggest a precise diagnosis but it is nevertheless essential to Neutropenia integrate these findings into the clinical context and take laboratory values into account. The use of endoscopy is still the rule where a doubt remains, or to obtain necessary histological evidence. © 2013 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved. Acute colitis is an acute condition of the colon and most often presents in the form of an acute abdominal picture with very variable clinical symptoms and laboratory test results. The most frequent symptoms encountered in colitis are abdominal pain, fever and diarrhoea [1]. Hyperleucocytosis and elevated CRP in laboratory tests are common.
    [Show full text]
  • MEGACOLON Parry R Photo: by Nadene Stapleton, Veterinary Surgeon
    HEALTH RMS is more commonly observed in older rabbits MEGACOLON Parry R Photo: By Nadene Stapleton, Veterinary Surgeon aving owned many species of pets over the years caecum and the colon that food is separated into two fractions. Material I am constantly in awe of my rabbits’ relationship high in indigestible fibre passes from the small intestine to the colon and Hwith food. I don’t believe I have come across out in the form of normal (copious) round poo particles which we know all another pet as food motivated as they are (it is as too well! though we are kindred spirits!). I often joke with other rabbit owners that my rabbits are just a ‘stomach Smaller, highly digestible particulate matter moves backwards from the covered in fluff’ personality-wise, but the same can be colon into the caecum where it is fermented to form caecotrophs which said for them anatomically as well. are then eaten by the rabbit from the rectum. The passage of material through the gut is helped by a wave of contractions of the wall of the The digestive system intestine known as peristalsis. It is a reduction in this normal movement of the gut wall that veterinarians refer to as ‘gut stasis’. There is a reason why descriptions of the digestive system of rabbits and gastrointestinal diseases affecting There is a very important and very complex area of the colon which is them make up such a large part of the rabbit veterinary rich in blood vessels and nerves called the ‘fusus coli’ (figure 1).
    [Show full text]